Please login to the form below

Not currently logged in

NeuroTherm appoints Gregory Cash as president and CEO

Joins pain management device manufacturers from HeartSine

Gregory Cash has been appointed president and CEO of US-based pain management device company NeuroTherm.

He joins from HeartSine Technologies, where he also served as president and CEO.

“This is a key appointment at an important time for NeuroTherm, and we are certain that Greg's leadership combined with his strategic vision  and experience make him the right person to lead the company through the next phase of rapid growth and development,” said Eric Bacon, chair of the board of directors at NeuroTherm.

Prior to his time at HeartSine, Cash served in numerous senior management roles of progressive responsibility in the US, Asia and Europe.

“While there are many challenges facing the medical device industry as a whole, NeuroTherm is poised for strong growth and will continue to make a positive difference in patients' lives,” said Cash.

24th September 2012

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Munro & Forster

At Munro & Forster we deliver real and lasting impact for our clients.We specialise in health and wellbeing, education and...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...